• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

连接酶检测反应与实时荧光定量聚合酶链反应检测慢性乙型肝炎患者低丰度YMDD变异体的比较

Comparison of ligase detection reaction and real-time PCR for detection of low abundant YMDD mutants in patients with chronic hepatitis B.

作者信息

Wang Xiao-Ling, Xie Song-Gang, Zhang Ling, Yang Wei-Xia, Wang Xing, Jin Hong-Zhi

机构信息

Laboratory Center, Subei People's Hospital, 98 West Nantong Road, Yangzhou 225001, Jiangsu Province, China.

出版信息

World J Gastroenterol. 2008 Jan 7;14(1):120-4. doi: 10.3748/wjg.14.120.

DOI:10.3748/wjg.14.120
PMID:18176973
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2673375/
Abstract

AIM

To compare the ligase detection reaction (LDR) and real-time PCR for detection of low abundant YMDD mutants in patients with chronic hepatitis B infection.

METHODS

Mixtures of plasmids and serum samples from 52 chronic hepatitis B patients with low abundant lamivudine-resistant mutations were tested with LDR and real-time PCR. Time required and reagent cost for both assays were evaluated.

RESULTS

Real-time PCR detected 100, 50, 10, 1 and 0.1% of YIDD plasmid, whereas LDR detected 100, 50, 10, 1, 0.1, and 0.01% of YIDD plasmid, in mixtures with YMDD plasmid of 10(6) copies/mL. Among the 52 clinical serum samples, completely concordant results were obtained for all samples by both assays, and 39 YIDD, 9 YVDD, and 4 YIDD/YVDD were detected. Cost and time required for LDR and real-time PCR are 60/80 CNY (8/10.7 US dollars) and 4.5/2.5 h, respectively.

CONCLUSION

LDR and real-time PCR are both sensitive and inexpensive methods for monitoring low abundant YMDD mutants during lamivudine therapy in patients with chronic hepatitis B. LDR is more sensitive and less expensive, while real-time PCR is more rapid.

摘要

目的

比较连接酶检测反应(LDR)和实时荧光定量聚合酶链反应(real-time PCR)检测慢性乙型肝炎感染患者中低丰度YMDD突变体的效果。

方法

采用LDR和实时荧光定量聚合酶链反应检测52例慢性乙型肝炎患者低丰度拉米夫定耐药突变的质粒和血清样本混合物。评估两种检测方法所需时间和试剂成本。

结果

在与10(6)拷贝/mL YMDD质粒混合的样本中,实时荧光定量聚合酶链反应能检测出100%、50%、10%、1%和0.1%的YIDD质粒,而LDR能检测出100%、50%、10%、1%、0.1%和0.01%的YIDD质粒。在52份临床血清样本中,两种检测方法对所有样本的检测结果完全一致,共检测出39例YIDD、9例YVDD和4例YIDD/YVDD。LDR和实时荧光定量聚合酶链反应的成本分别为60/80元人民币(8/10.7美元),所需时间分别为4.5/2.5小时。

结论

LDR和实时荧光定量聚合酶链反应都是监测慢性乙型肝炎患者拉米夫定治疗期间低丰度YMDD突变体的敏感且廉价的方法。LDR更敏感且成本更低,而实时荧光定量聚合酶链反应更快速。

相似文献

1
Comparison of ligase detection reaction and real-time PCR for detection of low abundant YMDD mutants in patients with chronic hepatitis B.连接酶检测反应与实时荧光定量聚合酶链反应检测慢性乙型肝炎患者低丰度YMDD变异体的比较
World J Gastroenterol. 2008 Jan 7;14(1):120-4. doi: 10.3748/wjg.14.120.
2
Comparison of amplicon-sequencing, pyrosequencing and real-time PCR for detection of YMDD mutants in patients with chronic hepatitis B.慢性乙型肝炎患者中用于检测YMDD突变体的扩增子测序、焦磷酸测序和实时PCR的比较
World J Gastroenterol. 2006 Nov 28;12(44):7192-6. doi: 10.3748/wjg.v12.i44.7192.
3
Detection of YMDD mutants using universal template real-time PCR.使用通用模板实时聚合酶链反应检测YMDD突变体
World J Gastroenterol. 2006 Feb 28;12(8):1308-11. doi: 10.3748/wjg.v12.i8.1308.
4
Application of PCR-LDR-nucleic acid detection strip in detection of YMDD mutation in hepatitis B patients treated with lamivudine.PCR-LDR-核酸检测条在拉米夫定治疗的乙型肝炎患者 YMDD 突变检测中的应用。
J Med Virol. 2010 Jul;82(7):1143-9. doi: 10.1002/jmv.21811.
5
High frequency of functional anti-YMDD and -mutant cytotoxic T lymphocytes after in vitro expansion correlates with successful response to lamivudine therapy for chronic hepatitis B.体外扩增后功能性抗-YMDD和突变型细胞毒性T淋巴细胞的高频率与慢性乙型肝炎拉米夫定治疗的成功应答相关。
Gut. 2005 Jan;54(1):152-61. doi: 10.1136/gut.2003.032920.
6
Hepatitis B virus quantification and detection of YMDD mutants in a single reaction by real-time PCR and annealing curve analysis.通过实时聚合酶链反应和退火曲线分析在单一反应中对乙型肝炎病毒进行定量及检测YMDD突变体
Antivir Ther. 2008;13(4):469-80.
7
[A real-time PCR assay for the quantification of hepatitis B virus DNA and concurrent detection of YMDD motif mutations].一种用于定量乙型肝炎病毒DNA及同时检测YMDD基序突变的实时聚合酶链反应检测法
Mikrobiyol Bul. 2011 Oct;45(4):664-76.
8
Prediction of breakthrough hepatitis due to lamivudine-resistant hepatitis B virus by a sensitive semiquantitative assay using peptide nucleic acids.
Intervirology. 2006;49(5):274-80. doi: 10.1159/000093457. Epub 2006 May 22.
9
[YMDD motif variants detected by Inno-Lipa HBV DR assay in chronic hepatitis B patients during lamivudine therapy].[拉米夫定治疗期间慢性乙型肝炎患者中通过Inno-Lipa HBV DR检测法检测到的YMDD基序变异]
Mikrobiyol Bul. 2008 Jul;42(3):445-50.
10
Rapid quantitation of lamivudine-resistant mutants in lamivudine treated and untreated patients with chronic hepatitis B virus infection.对接受和未接受拉米夫定治疗的慢性乙型肝炎病毒感染患者中拉米夫定耐药突变体进行快速定量分析。
Clin Chim Acta. 2006 Nov;373(1-2):172-5. doi: 10.1016/j.cca.2006.05.023. Epub 2006 May 22.

引用本文的文献

1
Effects of Tenofovir Combined with Recombinant Human Interferon -2b on Negative Conversion Rate, Liver Function, Immune Status, and Drug Safety in Patients with Chronic Hepatitis B: A Systematic Review and Meta-Analysis.替诺福韦联合重组人干扰素-2b对慢性乙型肝炎患者转阴率、肝功能、免疫状态及药物安全性的影响:一项系统评价与Meta分析
Evid Based Complement Alternat Med. 2022 Jun 30;2022:1889628. doi: 10.1155/2022/1889628. eCollection 2022.

本文引用的文献

1
Comparison of amplicon-sequencing, pyrosequencing and real-time PCR for detection of YMDD mutants in patients with chronic hepatitis B.慢性乙型肝炎患者中用于检测YMDD突变体的扩增子测序、焦磷酸测序和实时PCR的比较
World J Gastroenterol. 2006 Nov 28;12(44):7192-6. doi: 10.3748/wjg.v12.i44.7192.
2
Rapid quantitation of lamivudine-resistant mutants in lamivudine treated and untreated patients with chronic hepatitis B virus infection.对接受和未接受拉米夫定治疗的慢性乙型肝炎病毒感染患者中拉米夫定耐药突变体进行快速定量分析。
Clin Chim Acta. 2006 Nov;373(1-2):172-5. doi: 10.1016/j.cca.2006.05.023. Epub 2006 May 22.
3
Pegylated IFN-alpha 2b added to ongoing lamivudine therapy in patients with lamivudine-resistant chronic hepatitis B.聚乙二醇化干扰素α-2b添加至拉米夫定耐药慢性乙型肝炎患者正在进行的拉米夫定治疗中。
World J Gastroenterol. 2006 Apr 21;12(15):2417-22. doi: 10.3748/wjg.v12.i15.2417.
4
A novel method based on ligase detection reaction for low abundant YIDD mutants detection in hepatitis B virus.基于连接酶检测反应的新型方法用于检测乙型肝炎病毒中低丰度 YIDD 突变体。
Hepatol Res. 2006 Mar;34(3):150-5. doi: 10.1016/j.hepres.2005.12.007. Epub 2006 Feb 24.
5
The effect of pegylated interferon-alpha on the treatment of lamivudine resistant chronic HBeAg positive hepatitis B virus infection.聚乙二醇化干扰素-α对拉米夫定耐药的慢性HBeAg阳性乙型肝炎病毒感染的治疗效果。
J Hepatol. 2006 Mar;44(3):507-11. doi: 10.1016/j.jhep.2005.12.004. Epub 2006 Jan 19.
6
Dynamics of hepatitis B virus resistance to lamivudine.乙肝病毒对拉米夫定的耐药动态
J Virol. 2006 Jan;80(2):643-53. doi: 10.1128/JVI.80.2.643-653.2006.
7
Adefovir rapidly suppresses hepatitis B in HBeAg-negative patients developing genotypic resistance to lamivudine.阿德福韦能迅速抑制对拉米夫定产生基因型耐药的HBeAg阴性患者体内的乙肝病毒。
Hepatology. 2005 Dec;42(6):1414-9. doi: 10.1002/hep.20939.
8
A review of entecavir in the treatment of chronic hepatitis B infection.恩替卡韦治疗慢性乙型肝炎感染的综述。
Curr Med Res Opin. 2005 Nov;21(11):1845-56. doi: 10.1185/030079905X65268.
9
Systematic review: treatment of chronic hepatitis B virus infection by pegylated interferon.系统评价:聚乙二醇化干扰素治疗慢性乙型肝炎病毒感染
Aliment Pharmacol Ther. 2005 Sep 15;22(6):519-28. doi: 10.1111/j.1365-2036.2005.02616.x.
10
Advances in Molecular Diagnosis of HBV Infection and Drug Resistance.乙型肝炎病毒感染与耐药性的分子诊断进展
Int J Med Sci. 2005;2(1):8-16. doi: 10.7150/ijms.2.8. Epub 2005 Jan 5.